title: O PIONEERs! The Beginning of the End of Full-Dose Triple Therapy with Warfarin?
authors.affiliation: From Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA. dlbhattmd@post.harvard.edu.
authors.forename: Deepak L
authors.initials: DL
authors.lastname: Bhatt
mesh_terms: D000925:Anticoagulants; D004359:Drug Therapy, Combination; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin
keywords: Editorials